flag-tagged hdac5 double mutant (hdac5 s259a/s498a) (Addgene inc)
Structured Review
![( A ) Schematic workflow (left): HT29 cells were stably transfected with control (scrambled) or <t>HDAC5</t> shRNA. Volcano plot of up-regulated acetylated peptides upon HDAC5 depletion (right). ( B ) HT29 cells were infected with indicated adenoviruses. Twenty-four hours after infection, immunoprecipitation (IP) followed by Western blotting was performed. HA, hemagglutinin. ( C ) Glutathione S -transferase (GST) pull-down assay was performed. Western blotting was then performed for the indicated proteins. ( D ) HT29 cells were treated with 5-fluorouracil (5FU; 10 μM) for indicated time points. Western blotting was then performed from nuclear and cytoplasmic extracts. ( E ) HT29 cells were treated with 5FU (10 μM) for indicated time points, and the nuclear extracts were subjected to immunoprecipitation followed by immunoblotting. ( F ) HT29 cells were treated with 5FU (10 μM) for indicated time points, and the nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed. ( G and H ) HT29 control [Control; scrambled HDAC5 short hairpin RNA (shRNA)], HDAC5 knockdown (HDAC5kd; HDAC5 shRNA), and HDAC5 knockdown cells expressing HDAC5 mutant (HDAC5kd/HDAC5 S259/498A ) were subjected to proximity ligation assay (PLA) [(G), left]. Representative images are shown [(G), right]. Scale bars, 10 μm. The number of PLA foci per cell was quantified and plotted (H). Statistical analyses were done using two-way analysis of variance (ANOVA) (Bonferroni’s post hoc test). The data are representative of three independent experiments. Error bars are means ± SD. *** P < 0.001. ( I ) HT29 cells were transfected with an empty vector (EV) or the indicated FLAG-tagged PARP1 constructs. Twenty-four hours after transfection, nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed (left). Schematic representation of the PARP1 full-length and deletion mutants (right). ( J ) HT29 cells were transfected as indicated. Twenty-four hours after transfection, nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed (left). Schematic representation of the HDAC5 full-length and deletion mutants (right). (A), (G), (I), and (J) created with BioRender.com .](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_8539/pmc11488539/pmc11488539__sciadv.ado7720-f1.jpg)
Flag Tagged Hdac5 Double Mutant (Hdac5 S259a/S498a), supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/flag-tagged hdac5 double mutant (hdac5 s259a/s498a)/product/Addgene inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Temporal regulation of acetylation status determines PARP1 role in DNA damage response and metabolic homeostasis"
Article Title: Temporal regulation of acetylation status determines PARP1 role in DNA damage response and metabolic homeostasis
Journal: Science Advances
doi: 10.1126/sciadv.ado7720
Figure Legend Snippet: ( A ) Schematic workflow (left): HT29 cells were stably transfected with control (scrambled) or HDAC5 shRNA. Volcano plot of up-regulated acetylated peptides upon HDAC5 depletion (right). ( B ) HT29 cells were infected with indicated adenoviruses. Twenty-four hours after infection, immunoprecipitation (IP) followed by Western blotting was performed. HA, hemagglutinin. ( C ) Glutathione S -transferase (GST) pull-down assay was performed. Western blotting was then performed for the indicated proteins. ( D ) HT29 cells were treated with 5-fluorouracil (5FU; 10 μM) for indicated time points. Western blotting was then performed from nuclear and cytoplasmic extracts. ( E ) HT29 cells were treated with 5FU (10 μM) for indicated time points, and the nuclear extracts were subjected to immunoprecipitation followed by immunoblotting. ( F ) HT29 cells were treated with 5FU (10 μM) for indicated time points, and the nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed. ( G and H ) HT29 control [Control; scrambled HDAC5 short hairpin RNA (shRNA)], HDAC5 knockdown (HDAC5kd; HDAC5 shRNA), and HDAC5 knockdown cells expressing HDAC5 mutant (HDAC5kd/HDAC5 S259/498A ) were subjected to proximity ligation assay (PLA) [(G), left]. Representative images are shown [(G), right]. Scale bars, 10 μm. The number of PLA foci per cell was quantified and plotted (H). Statistical analyses were done using two-way analysis of variance (ANOVA) (Bonferroni’s post hoc test). The data are representative of three independent experiments. Error bars are means ± SD. *** P < 0.001. ( I ) HT29 cells were transfected with an empty vector (EV) or the indicated FLAG-tagged PARP1 constructs. Twenty-four hours after transfection, nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed (left). Schematic representation of the PARP1 full-length and deletion mutants (right). ( J ) HT29 cells were transfected as indicated. Twenty-four hours after transfection, nuclear extracts were subjected to immunoprecipitation. Western blotting was then performed (left). Schematic representation of the HDAC5 full-length and deletion mutants (right). (A), (G), (I), and (J) created with BioRender.com .
Techniques Used: Stable Transfection, Transfection, Control, shRNA, Infection, Immunoprecipitation, Western Blot, Pull Down Assay, Knockdown, Expressing, Mutagenesis, Proximity Ligation Assay, Plasmid Preparation, Construct
Figure Legend Snippet: ( A ) HT29 control (Control; scrambled HDAC5 shRNA) and HDAC5 knockdown (HDAC5kd; HDAC5 shRNA) cells were treated with 5FU (10 μM) for indicated time points. Western blotting was then performed for the indicated proteins from nuclear extracts. ( B ) HT29 cells were stably transfected (pooled zeomycin-resistant population) with control (Control; Scrambled p300 shRNA) or p300 knockdown (p300kd; p300 shRNA). These cells were treated with 5FU (10 μM) for indicated time points. Western blotting was then performed for the indicated proteins from nuclear extracts. ( C ) HT29 PARP1 and HDAC5 double knockdown (HDAC5kd/PARP1kd; HDAC5 and PARP1 shRNA) cells were transfected with FLAG-tagged wild-type PARP1, PARP1 K498R , PARP1 K505R , PARP1 K508R , PARP1 K521R , or PARP1 K532R constructs as indicated. Twenty-four hours after transfections nuclear extracts were prepared and subjected to immunoprecipitation followed by Western blotting for the indicated proteins. ( D ) AcK498-PARP1 and AcK521-PARP1 peptides were incubated either alone (Control) or in the presence of recombinant HDAC5. Mass spectrometry was then performed. The relative positions of acetylated Lys 498 (1068.60 Da) and Lys 521 (1389.79 Da), while deacetylated Lys 498 (1026.60 Da) and Lys 521 (1347.79 Da) PARP1 peptides are indicated. m/z , mass/charge ratio. ( E ) Results of HDAC5 deacetylation reactions using acetylated PARP1 peptides. ( F ) Schematic representation of the PARP1 domains. The lysine residues in the automodification domain are sites of HDAC5-mediated deacetylation. Created with BioRender.com . ( G ) The amino acid sequence encompassing human PARP1 K498 (red) and K521 (blue) residue. ( H ) HT29 control (Control; scrambled HDAC5 shRNA) and HDAC5 knockdown (HDAC5kd; HDAC5 shRNA) cells were treated with 5FU (10 μM) for indicated time points. Western blotting was then performed for the indicated proteins. ( I ) HT29 HDAC5 knockdown (HDAC5kd; HDAC5 shRNA) cells were stably transfected with Flag-tagged HDAC5 mutant constructs. These cells were treated with 5FU (10 μM) for indicated time points. Western blotting was then performed for the indicated proteins.
Techniques Used: Control, shRNA, Knockdown, Western Blot, Stable Transfection, Transfection, Construct, Immunoprecipitation, Incubation, Recombinant, Mass Spectrometry, Sequencing, Residue, Mutagenesis
Figure Legend Snippet: ( A ) Schematic representation of workflow to identify mutant PARP1 binding proteins upon 5FU (10 μM) treatment for 12 hours in HT29 cells (left). Volcano plot of proteins interacting with PARP1 mutant (PARP1 K521R ) (right). Created with BioRender.com . ( B ) HT29 PARP1 knockdown (PARP1kd; PARP1 shRNA) cells were transfected with EV or FLAG-tagged wild-type or mutant PARP1 constructs as indicated. Twenty-four hours after transfection, the cells were treated with 5FU (10 μM) for 12 hours. Immunoprecipitation followed by Western blotting for the indicated proteins was performed. ( C and D ) HT29 control (Control; Luc shRNA), HDAC5 knockdown (HDAC5kd; HDAC5 shRNA), and PARP1 knockdown cells (PARP1kd; PARP1 shRNA) expressing PARP1 mutants and HDAC5 knockdown cells expressing HDAC5 mutants were treated with 5FU (10 μM) for indicated time points. PLA was performed (C). Scale bars, 10 μm. The number of PLA foci per cell was quantified and plotted (D). Statistical analyses were done using two-way ANOVA (Bonferroni’s post hoc test). Error bars are means ± SD. ** P < 0.01; *** P < 0.001. ( E ) HT29 control (Control) and HDAC5 knockdown (HDAC5kd) cells were treated with 5FU (10 μM) for indicated time points. Western blotting was then performed. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. ( F ) HT29 control (Control; Luc shRNA), PARP1 knockdown cells expressing PARP1 K521R (PARP1 K521R ), as well as PARP1 and activating transcription factor 4 (ATF4) double knockdown cells (PARP1 and ATF4 shRNA) expressing PARP1 K521R (PARP1 K521R /ATF4kd) were treated with 5FU and subjected to RNA sequencing analysis. Red and blue indicate up-regulation and down-regulation, respectively. ( G ) HT29 control (Control; Luc shRNA), HDAC5 knockdown (HDAC5kd), PARP1 knockdown cells expressing PARP1 mutants, and HDAC5 knockdown cells expressing HDAC5 mutants were treated with 5FU (10 μM) for indicated time points. A reverse transcription quantitative polymerase chain reaction was performed. Statistical analyses were done using two-way ANOVA (Tukey’s post hoc test). Error bars are means ± SD of three independent experiments with triplicate samples. *** P < 0.001.
Techniques Used: Mutagenesis, Binding Assay, Knockdown, shRNA, Transfection, Construct, Immunoprecipitation, Western Blot, Control, Expressing, RNA Sequencing Assay, Reverse Transcription, Real-time Polymerase Chain Reaction
Figure Legend Snippet: ( A ) HT29 control (Control; Luc shRNA), HDAC5 knockdown (HDAC5kd; HDAC5 shRNA), PARP1 knockdown (PARP1kd; PARP1 shRNA), PARP1 knockdown cells expressing PARP1 K521R (PARP1 K521R ), as well as PARP1 and ATF4 double knockdown cells expressing PARP1 K521R (PARP1 K521R /ATF4kd) were treated with 5FU (10 μM) for 12 hours. The metabolites were extracted from the harvested cells and analyzed by liquid chromatography–mass spectrometry (LC-MS). Relative levels of specific metabolites normalized to cell number are shown in the heatmap. The heatmap depicts relative changes in intracellular metabolites. Orange and cyan indicate up-regulation and down-regulation, respectively. ( B ) Metabolic pathway enrichment analysis of (A). Metabolite data are representative of three independent experiments. ( C to G ) HT29 control (Control), HDAC5 knockdown (HDAC5kd), PARP1 knockdown (PARP1kd), PARP1 knockdown cells expressing PARP1 K521Q (PARP1 K521Q ) or PARP1 K521R (PARP1 K521R ), PARP1 and ATF4 double knockdown cells expressing PARP1 K521R (PARP1 K521R /ATF4kd), as well as HDAC5 knockdown cells expressing HDAC5 S259/498A (HDAC5kd/HDAC5 S259/498A ) were treated with 5FU (10 μM) for indicated time points. The cells were harvested, and metabolites were extracted. The relative amounts of the indicated metabolites were quantified using respective kits. Statistical analyses were done using two-way ANOVA (Bonferroni’s post hoc test). The data are representative of three independent experiments. Error bars are means ± SD. *** P < 0.001. ( H ) HT29 control (Control), HDAC5 knockdown (HDAC5kd), PARP1 knockdown (PARP1kd), as well as PARP1 knockdown cells expressing PARP1 K521Q (PARP1kd/PARP1 K521Q ) or PARP1 K521R (PARP1kd/PARP1 K521R ), PARP1 and ATF4 double knockdown cells expressing PARP1 K521R (PARP1 K521R /ATF4kd), and HDAC5 knockdown cells expressing HDAC5 S259/498A (HDAC5kd/HDAC5 S259/498A ) were treated with 5FU (10 μM) for indicated time points. The cellular oxygen consumption rate (OCR) was then measured. The data are representative of three independent experiments.
Techniques Used: Control, shRNA, Knockdown, Expressing, Liquid Chromatography, Mass Spectrometry, Liquid Chromatography with Mass Spectroscopy
Figure Legend Snippet: ( A ) HT29 Luc2 control (Control; Luc shRNA); HDAC5 knockdown (HDAC5kd; HDAC5 shRNA); PARP1 knockdown (PARP1kd; PARP1 shRNA); PARP1 knockdown cells (PARP1kd; PARP1 shRNA) expressing PARP1 K498R (PARP1kd/PARP1 K498R ), PARP1 K521R (PARP1kd/PARP1 K521R ), or PARP1 K498R,521R (PARP1kd/PARP1 K498R,521R ); and HDAC5 knockdown cells expressing HDAC5 S259/498A (HDAC5kd/HDAC5 S259/498A ) were orthotopically injected into the cecum wall of nude mice. After 1 week, mice were administered 5FU (10 mg/kg) every alternate day. Olaparib was also coadministered at a dose of 10 mg/kg daily as indicated. Bioluminescence imaging was performed. ( B ) Bioluminescence quantification [(A) above]. The data are representative of three independent experiments using five individual mice per group. Error bars are means ± SD from five individual mice ( n = 5 mice per group). Statistical analyses were done using two-way ANOVA (Tukey’s post hoc test). *** P < 0.001. ( C and D ) At the end of 5 weeks, the liver and lung from indicated mice [(A) above] were analyzed by ex vivo imaging (C) and hematoxylin and eosin staining (D). ( E ) At the end of 5 weeks, the blood from mice in (A) above was used to isolate genomic DNA for examining circulating tumor cells. The data are representative of three independent experiments using five individual mice per group. Error bars are means ± SD from five individual mice ( n = 5 mice per group) * P < 0.05; ** P < 0.01; *** P < 0.001. ( F ) At the end of 5 weeks, lysates of primary orthotopic tumors from (A) above were analyzed by immunoblotting for the indicated proteins. ( G and H ) Representative image of immunostaining of the indicated proteins in different grades of colon adenocarcinoma and matched normal adjacent tissue (NAT) (G). Quantitation of HDAC5, AcK498-PARP1, and AcK521-PARP1 levels (H). Statistical analyses were done using one-way ANOVA (Dunn’s multiple comparison test). Error bars are means ± SD. ** P < 0.01; *** P < 0.001.
Techniques Used: Control, shRNA, Knockdown, Expressing, Injection, Imaging, Ex Vivo, Staining, Western Blot, Immunostaining, Quantitation Assay, Comparison


